Panbela to host virtual r&d day

Minneapolis, april 27, 2022 (globe newswire) -- panbela therapeutics, inc. (nasdaq: pbla), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, will host an r&d call on tuesday, may 03, 2022 at 9:00 am eastern time. panbela's management team will be joined by leading experts for a deep dive on the company's investigational drug, sbp-101, as a polyamine metabolism modulator in ovarian cancer.
PBLA Ratings Summary
PBLA Quant Ranking